Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Millennium: The Takeda Oncology Company
Lobbying Relationship
Bills mentioned
H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
H.R.1548: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
S.726: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Charles E. Schumer (D-N.Y.)
H.R.6331: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Charles B. Rangel (D-N.Y.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| John M. Haddow | Legislative Assistant |
| William Nixon | Senior Policy Advisor/Communications Director |
| John Drew Hiatt | Staff Director for the Small Business Committee |
| Matthew Salmon | U.S. Representative from Arizona's 1st District |
| Alvin Jackson | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate